155 related articles for article (PubMed ID: 28867690)
1. Effects of Calcium-Channel Blocker Benidipine-Based Combination Therapy on Cardiac Events - Subanalysis of the COPE Trial.
Umemoto S; Ogihara T; Matsuzaki M; Rakugi H; Shimada K; Kawana M; Kario K; Ohashi Y; Saruta T;
Circ J; 2018 Jan; 82(2):457-463. PubMed ID: 28867690
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
Matsuzaki M; Ogihara T; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Abe K; Suzuki N; Eto T; Higaki J; Ito S; Kamiya A; Kikuchi K; Suzuki H; Tei C; Ohashi Y; Saruta T;
J Hypertens; 2011 Aug; 29(8):1649-59. PubMed ID: 21610513
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
4. Effects of an Antihypertensive Combination in Japanese Hypertensive Outpatients Based on the Long-acting Calcium Channel Blocker Benidipine on Vascular and Renal Events: A Sub-analysis of the COPE Trial.
Umemoto S; Ogihara T; Matsuzaki M; Rakugi H; Shimada K; Hayashi K; Makino H; Ohashi Y; Saruta T
Curr Hypertens Rev; 2020; 16(3):238-245. PubMed ID: 31995012
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.
Umemoto S; Ogihara T; Matsuzaki M; Rakugi H; Ohashi Y; Saruta T;
Hypertens Res; 2016 Jan; 39(1):46-53. PubMed ID: 26490089
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.
Rakugi H; Ogihara T; Umemoto S; Matsuzaki M; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2013 Nov; 36(11):947-58. PubMed ID: 23864054
[TBL] [Abstract][Full Text] [Related]
7. Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.
Umemoto S; Ogihara T; Matsuzaki M; Rakugi H; Ohashi Y; Saruta T;
Hypertens Res; 2017 Apr; 40(4):376-384. PubMed ID: 27904156
[TBL] [Abstract][Full Text] [Related]
8. Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial.
Umemoto S; Ogihara T; Rakugi H; Matsumoto M; Kitagawa K; Shimada K; Higaki J; Ito S; Suzuki H; Ohashi Y; Saruta T; Matsuzaki M;
Hypertens Res; 2013 Dec; 36(12):1088-95. PubMed ID: 23985703
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
Ogawa H; Kim-Mitsuyama S; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K;
Am J Med; 2012 Oct; 125(10):981-90. PubMed ID: 22503610
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
Yamada H; Suga N; Maeda K; Kimura Y; Miura N; Futenma A; Imai H
Arzneimittelforschung; 2010; 60(2):64-70. PubMed ID: 20329653
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
[TBL] [Abstract][Full Text] [Related]
13. Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats.
Takayama M; Arakawa E; Yao K; Ina Y; Sato H; Hasegawa K; Kohno H; Ohno T
Pharmacology; 2006; 77(4):179-87. PubMed ID: 16864986
[TBL] [Abstract][Full Text] [Related]
14. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria.
Saito F; Fujita H; Takahashi A; Ichiyama I; Harasawa S; Oiwa K; Takahashi N; Otsuka Y; Uchiyama T; Kanmatsuse K; Kushiro T
Hypertens Res; 2007 Jan; 30(1):39-47. PubMed ID: 17460370
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
Chen JM; Heran BS; Perez MI; Wright JM
Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
[TBL] [Abstract][Full Text] [Related]
17. One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease.
Tomino Y; Shimizu Y; Hamada C; Kurusu A; Ohsawa I; Suzuki Y; Tsuge T; Io H; Kobayashi N; Takeda Y; Asanuma K; Tanaka Y; Suzuki H; Nakata J; Takara K; Horikoshi S
J Nephrol; 2011; 24(6):756-63. PubMed ID: 21360472
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
Miyagawa K; Dohi Y; Nakazawa A; Sugiura T; Yamashita S; Sato K; Kimura G
Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
[TBL] [Abstract][Full Text] [Related]
19. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
